4//SEC Filing
Donegan Michael C 4
Accession 0001209191-23-024386
CIK 0000025743other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 7:17 PM ET
Size
7.6 KB
Accession
0001209191-23-024386
Insider Transaction Report
Form 4
Donegan Michael C
Vice President Finance
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-04-12−50,000→ 0 totalExercise: $0.00→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2023-04-12+50,000→ 61,853 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer common stock upon settlement. On April 12, 2023, the reporting person received 50,000 shares of issuer common stock in settlement of restricted stock units (RSUs).
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in full on March 31, 2023.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001627810
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 7:17 PM ET
- Size
- 7.6 KB